ILMN vs LAB · rev $4.34B vs rev $174.4M
Illumina Inc (ILMN) versus Standard Biotools Inc (LAB) — a side-by-side from cached financials, not a winner call.
Illumina Inc (ILMN) is a diagnostics & research company listed on US.
Standard Biotools Inc (LAB) is a medical devices company listed on NASDAQ.
Latest reported ILMN revenue for 2025-12-28 was $4.34B. Net income was $850.0M. Revenue was down 0.7% from 2024-12-29 to 2025-12-28. ILMN currently screens at market cap $15.84B.
Latest reported LAB revenue for 2024-12-31 was $174.4M. Net income was -$138.9M. Revenue was up 64.0% from 2023-12-31 to 2024-12-31. LAB currently screens at market cap $317.1M.
ILMN currently screens at market cap $15.84B. LAB currently screens at market cap $317.1M.
Not investment advice. Open the ILMN and LAB stock pages for the full models.
Not investment advice.